Biomedical Sealant Market Explores New Growth OpportunitiesPosted by Rajkumar on March 18th, 2019 Biomedical sealants have emerged as a promising product for replacing staples and sutures to prevent liquid and air leakages after and during surgeries. Surgical sealants are made from synthetic or natural polymers or a combination of both. Sealant materials are required to be elastic and compliant with the tissue to allow movement and function of various tissues of lungs, blood vessel, skin, and heart. These materials include polyurethane, glycol, and polyethylene glycol or naturally occurring polysaccharides or proteins. Polyurethane is used in biomedical sealants due to its property of strong adhesion and high elasticity to tissues. Polyethylene glycol in sealants is widely used as hemostatic adhesive and fluid barrier.
Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1936
Biomedical Sealant Market Drivers:-
Approval of new biomedical sealants in key regions such as Europe is expected to drive growth of the biomedical sealant market. For instance, in 2017, Starch Medical, marketer and manufacturer of polysaccharide-based hemostatic products such as biomedical sealants was approved by C.E. Mark for Super Clot. Post the approval, company has planned to utilize their existing network of distribution partners along with their new strategic partners to bring Super Clot to hospitals and surgical teams throughout Europe. This strategic planning of product distribution is expected to fuel growth of the global biomedical sealant market.
Biomedical Sealant Market Regional Analysis:-
North America is expected to be dominant in the global biomedical sealant market over the forecast period. This is due to increasing product launches by key players in the region. For instance, in 2017, Starch Medical, a marketer and manufacturer of polysaccharide-based hemostatic products such as biomedical sealants, launched its new product Super Clot. Super Clot is a biomedical sealant used for effective and rapid hemostasis. Such new products in the market are expected to boost growth of the North America biomedical sealant market.
Biomedical Sealant Market Key Players:-
Key players operating in the global biomedical sealant include Bostik, 3M Company, Henkel AG & company, KGaA., CryoLife Inc., Chemence Ltd., Cyberbond LLC., Ethicon Inc., Covidien PLC., Glustitch Inc., Adhezion Biomedical LLC., Cohera Medical Inc., Baxter International Inc., Meyer Haake GmbH, Angiotech Pharmaceuticals Inc., and Biocoral Inc.
Biomedical Sealant Market Taxonomy:-
By Product Type:-
By Applications:-
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com Like it? Share it! More by this author |